Thrombolex has filed a notice of an exempt offering of securities to raise $4,839,829.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Thrombolex is raising up to $4,839,829.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Michael Cerminaro played a key…
